Fennec Pharmaceuticals Inc. - SIC # 8110 -

Ticker Exchange SIC # Website Latest Ticker
FENC Nasdaq 8110 www.fennecpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Fennec Pharmaceuticals Inc.

Insider Favorites High Growth Companies June 2026 - Jun 8th, 2026 5:35 am
Adherex Technologies’ PEDMARK Push Targets Larger AYA Market After Record Quarter - May 23rd, 2026 8:05 am
Fennec Announces New Research Supporting Pedmark's Use at ASCO Annual Meeting - May 22nd, 2026 5:21 am
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting - May 21st, 2026 4:01 pm
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 18th, 2026 2:30 pm
Fennec Pharmaceuticals Inc (FENC) Q1 2026 Earnings Call Highlights: Record Sales Surge and ... - May 14th, 2026 5:03 pm
Fennec Pharmaceuticals Inc. Q1 2026 Earnings Call Summary - May 14th, 2026 3:11 pm
Do Options Traders Know Something About Adherex Technologies Stock We Don't? - May 14th, 2026 9:32 am
Adherex Technologies Q1 Earnings Call Highlights - May 14th, 2026 9:06 am
Fennec Pharmaceuticals Shares Rise After Earnings and Revenue Beat Forecasts (FENC) - May 14th, 2026 6:47 am
Fennec Pharmaceuticals up 12.6% in U.S. Pre-Market on Q1 Earnings as Pedmark Sales Jump 73% - May 14th, 2026 5:45 am
Adherex Technologies Inc. (FENC) Beats Q1 Earnings and Revenue Estimates - May 14th, 2026 5:40 am
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update - May 14th, 2026 4:30 am
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates - May 12th, 2026 3:40 pm
Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Lags Revenue Estimates - May 7th, 2026 6:50 am
Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026 - May 7th, 2026 4:36 am
Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting - Apr 21st, 2026 2:30 pm
Wedbush Refines Fennec Pharmaceuticals Estimates Ahead of Q1 Earnings - Apr 16th, 2026 9:40 am
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center - Apr 7th, 2026 5:03 am
Companies Like Fennec Pharmaceuticals (NASDAQ:FENC) Can Afford To Invest In Growth - Mar 26th, 2026 4:22 am